Mirtazapine augmentation for selective serotonin reuptake inhibitor-induced sexual dysfunction: A retropective investigation

Psychiatry Investigation

Volumn 8, Issue 1, 2011, Pages 55-57

  Atmaca, Murad ^a   Korkmaz, Sevda ^a   Topuz, Mehtap ^a   Mermi, Osman ^a  

^a FIRAT UNIVERSITY   (Turkey)

Author keywords

Mirtazapine; Sexual dysfunction; SSRI

Indexed keywords

CITALOPRAM; CLOMIPRAMINE; ESCITALOPRAM; FLUVOXAMINE; MIRTAZAPINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ADD ON THERAPY; ADULT; AGED; ANORGASMIA; ARTICLE; CLINICAL ARTICLE; ERECTILE DYSFUNCTION; FEMALE; HUMAN; LIBIDO; LOW DRUG DOSE; LUBRICATION DISORDER; MAJOR DEPRESSION; MALE; MEDICAL RECORD REVIEW; MONOTHERAPY; OBSERVATIONAL STUDY; ORGASM DISORDER; RETROSPECTIVE STUDY; SEXUAL DYSFUNCTION; SIDE EFFECT; TREATMENT DURATION;

EID: 79955509677     PISSN: 17383684     EISSN: None     Source Type: Journal    
DOI: 10.4306/pi.2011.8.1.55     Document Type: Article

References (12)

1. Hu XH, Bull SA, Hunkeler EM, Ming E, Lee JY, Fireman B, et al. Incidence and duration of side effects and those rated as bothersome with selective serotonin reuptake inhibitor treatment for depression: patient report versus physician estimate. J Clin Psychiatry 2004;65:959-965.
2. Devoto P, Flore G, Pira L, Longu G, Gessa GL Mirtazapine-induced corelease of dopamine and noradrenaline from noradrenergic neurons in the medial prefrontal and occipital cortex. Eur J Pharmacol 2004;487: 105-111.
3. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62.
4. McGahuey CA, Gelenberg AJ, Laukes CA, Manber R, McKnight KM, Moreno FA, et al. The Arizona Sexual Experience Scale: validity and reliability. Proceedings of the Annual Meeting of the American Psychiatric Association 1997:17-22.
5. Aizenberg D, Naor S, Zemishlany Z, Weizman A. The serotonin antagonist mianserin for treatment of serotonin reuptake inhibitor-induced sexual dysfunction in women: an open-label add-on study. Clin Neuropharmacol 1999;22:347-350.
6. Hollander E, McCarley A. Yohimbine treatment of sexual side effects induced by serotonin reuptake blockers. J Clin Psychiatry 1992;53:207-209.
7. Koutouvidis N, Pratikakis M, Fotiadou A. The use of mirtazapine in a group of 11 patients following poor compliance to selective serotonin reuptake inhibitor treatment due to sexual dysfunction. Int Clin Psychopharmcol 1999;14:253-255.
8. Gelenberg AJ, McGahuey C, Laukes C, Okayli G, Moreno F, Zentner L, et al. Mirtazapine substituon in SSRI-induced sexual dysfunction. J Clin Psychiatry 2000;61:356-360.
9. Michelson D, Kociban K, Tamura R, Morrison MF. Mirtazapine, yohimbine or olanzapine augmentation therapy for serotonin reuptake-associated female sexual dysfunction: a randomized, placebo controlled trial. J Psychiatr Res 2002;36:147-152.
10. Ozmenler NK, Karlidere T, Bozkurt A, Yetkin S, Doruk A, Sutcigil L, et al. Mirtazapine augmentation in depressed patients with sexual dysfunction due to selective serotonin reuptake inhibitors. Hum Psychopharmacol 2008;23:321-326.
11. Montgomery SA. Safety of mirtazapine: a review. Int Clin Psychopharmacol 1995;10 Suppl 4:37-45.
12. Hull EM, Muschamp JW, Sato S. Dopamine and serotonin: influences on male sexual behavior. Physiol Behav 2004;83:291-307.